WallStreetZenWallStreetZen

NASDAQ: SPRY
Ars Pharmaceuticals Inc Stock Forecast, Predictions & Price Target

Analyst price target for SPRY

Based on 1 analyst offering 12 month price targets for Ars Pharmaceuticals Inc.
Min Forecast
$13.00+49.25%
Avg Forecast
$13.00+49.25%
Max Forecast
$13.00+49.25%

Should I buy or sell SPRY stock?

Based on 1 analyst offering ratings for Ars Pharmaceuticals Inc.
Buy
Strong Buy
0 analysts 0%
Buy
1 analysts 100%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their SPRY stock forecasts and price targets.

SPRY stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2023-11-13

1 of 1

Forecast return on equity

Is SPRY forecast to generate an efficient return?
Company
N/A
Industry
N/A
Market
34.96%

Forecast return on assets

Is SPRY forecast to generate an efficient return on assets?
Company
N/A
Industry
N/A

SPRY revenue forecast

What is SPRY's revenue in the next 3 years based on estimates from 2 analysts?
Avg 1 year Forecast
$6.1M+350.22%
Avg 2 year Forecast
$70.3M+5,123.33%
Avg 3 year Forecast
$154.3M+11,365.45%
SPRY's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

SPRY earnings growth forecast

How is SPRY forecast to perform vs Biotechnology companies and vs the US market?
Company
-13.78%
Industry
6.69%
Market
22.27%
SPRY's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Industry Forecast
SPRY's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Market Forecast
SPRY's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Savings Rate Forecast

SPRY revenue growth forecast

How is SPRY forecast to perform vs Biotechnology companies and vs the US market?
Company
381.32%
Industry
45.76%
Market
10.79%
SPRY's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
SPRY's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

SPRY vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
SPRY$8.71$13.00+49.25%Buy
AUPH$5.78$10.33+78.77%Strong Buy
SLRN$8.63$14.80+71.49%Buy
ALLO$4.94$8.33+68.68%Strong Buy
OCUL$10.75$15.00+39.53%Strong Buy

Ars Pharmaceuticals Stock Forecast FAQ

Is Ars Pharmaceuticals Stock a good buy in 2024, according to Wall Street analysts?

The consensus among 1 Wall Street analyst covering (NASDAQ: SPRY) stock is to Buy SPRY stock.

Out of 1 analyst, 0 (0%) are recommending SPRY as a Strong Buy, 1 (100%) are recommending SPRY as a Buy, 0 (0%) are recommending SPRY as a Hold, 0 (0%) are recommending SPRY as a Sell, and 0 (0%) are recommending SPRY as a Strong Sell.

If you're new to stock investing, here's how to buy Ars Pharmaceuticals stock.

What is SPRY's revenue growth forecast for 2024-2026?

(NASDAQ: SPRY) Ars Pharmaceuticals's forecast annual revenue growth rate of 381.32% is forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 45.76%, and it is also forecast to beat the US market's average forecast revenue growth rate of 10.79%.

Ars Pharmaceuticals's revenue in 2024 is $1,346,000.On average, 2 Wall Street analysts forecast SPRY's revenue for 2024 to be $581,743,347, with the lowest SPRY revenue forecast at $527,984,886, and the highest SPRY revenue forecast at $635,501,808. On average, 3 Wall Street analysts forecast SPRY's revenue for 2025 to be $6,749,182,799, with the lowest SPRY revenue forecast at $2,659,123,880, and the highest SPRY revenue forecast at $13,151,623,524.

In 2026, SPRY is forecast to generate $14,814,775,915 in revenue, with the lowest revenue forecast at $5,011,056,554 and the highest revenue forecast at $24,618,495,275.

What is SPRY's forecast return on assets (ROA) for 2024-2027?

(NASDAQ: SPRY) forecast ROA is N/A, which is lower than the forecast US Biotechnology industry average of N/A.

What is SPRY's Price Target?

According to 1 Wall Street analyst that have issued a 1 year SPRY price target, the average SPRY price target is $13.00, with the highest SPRY stock price forecast at $13.00 and the lowest SPRY stock price forecast at $13.00.

The Wall Street analyst predicted that Ars Pharmaceuticals's share price could reach $13.00 by Nov 13, 2024. The average Ars Pharmaceuticals stock price prediction forecasts a potential upside of 49.25% from the current SPRY share price of $8.71.

What is SPRY's forecast return on equity (ROE) for 2024-2027?

(NASDAQ: SPRY) forecast ROE is N/A, which is considered weak.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.